Skip to main content

Vitamins and Supplements

  • Chapter
  • First Online:
Interpreting Health Benefits and Risks

Abstract

Although many Americans take vitamins and supplements, there is little objective data available regarding their benefits and risks, and they are not tightly regulated by the FDA. Studies of multivitamins and anti-oxidant pills have not shown them to be effective in disease prevention. The benefits and risks of eye vitamins, fish oil, Vitamin E, and Folic Acid are also assessed. There continues to be confusion regarding the benefits and risks of supplement use. Information presented to doctors and patients tends to be misleading and difficult to interpret. This is due, in large part, to the use of relative risks rather than absolute values when communicating information on supplement benefits. In light of this situation, a unique graphic, functioning as a decision aid, has been developed to enable physicians and patients to jointly assess the benefits and risks of vitamin and supplement use. By characterizing the complexities of risk analysis in terms patients can understand, means they will be able to make well-informed decisions about their health.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Notes

  1. 1.

    http://www.uspreventiveservicestaskforce.org/uspstf/uspsvita.htm.

  2. 2.

    http://www.nlm.nih.gov/medlineplus/druginfo/natural/938.html.

  3. 3.

    http://www.medscape.com/viewarticle/805099.

References

  1. HOPE-TOO Trial Investigators. (2005). Long term vitamin e supplements in patients with vascular disease or diabetes. Journal of American Medical Association, 2005(293), 138–147.

    Google Scholar 

  2. Miller, E. R., et al. (2005). Meta-analysis: High-dosage vitamin e supplementation may increase all-cause mortality. Annals of Internal Medicine, 142(1), 37–46.

    Article  CAS  PubMed  Google Scholar 

  3. Klein, E. A., et al. (2011). Vitamin E and the risk of prostate cancer: the selenium and vitamin E cancer prevention trial. Journal of American Medical Association, 306, 1549–1555.

    Article  CAS  Google Scholar 

  4. Searing, L. (2014). A daily dose of vitamin E may slow early Alzheimer’s disease. The Washington Post, 4(2014), E3.

    Google Scholar 

  5. Miller, E. R., et al. (2010). Meta-analysis of folic acid supplementation trials on risk of cardiovascular disease and risk interaction with baseline homocysteine levels. American Journal of Cardiology, 106(4), 517–527.

    Article  PubMed  Google Scholar 

  6. Clark, R., et al. (2010). Effects of lowering homocysteine levels with b vitamins on cardiovascular disease, cancer, and cause-specific mortalitymeta-analysis of 8 randomized trials involving 37,485 individuals. Archives of Internal Medicine, 170(18), 1622–1631.

    Article  Google Scholar 

  7. Albert, C. M., et al. (2008). Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among females at high risk for cardiovascular disease. Journal of American Medical Association, 2008(299), 2027–2031.

    Article  Google Scholar 

  8. Kwak, S., et al. (2012). Efficacy of omega-3 fatty acid supplements in the secondary prevention of cardiovascular disease. Archives of Internal Medicine, 175(9), 686–694.

    Google Scholar 

  9. Risk and Prevention Study Collaborative Group. (2013). N-3 fatty acids in patients with multiple cardiovascular risk factors. New England Journal of Medicine, 368, 1800–1808.

    Article  Google Scholar 

  10. Rizos, E., et al. (2012). Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: A systematic review and meta-analysis. Journal of American Medical Association, 308(10), 1024–1033.

    Article  CAS  Google Scholar 

  11. Brasky, T. M., et al. (2013). Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial. Journal of the National Cancer Institute, 105(15), 1132–1141.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  12. Gellar, E., et al. (2013). Enough is enough: Stop wasting money on vitamin and mineral supplements. Annals of Internal Medicine, 159(12), 850–851.

    Google Scholar 

  13. Fortmann, S., et al. (2013). Vitamin and mineral supplements in the primary prevention of cardiovascular disease and cancer: An updated systematic evidence review for the U.S. preventive services task force. Annals of Internal Medicine, 159(12), 824–834.

    Article  PubMed  Google Scholar 

  14. Myung, S., et al. (2013). Efficacy of vitamin and antioxidant supplements in prevention of cardiovascular disease: systematic review and meta-analysis of randomised controlled trials. British Medical Journal, 346, f10.

    Article  PubMed Central  PubMed  Google Scholar 

  15. Bjelakovic, G., et al. (2007). Mortality in randomized trials of antioxidant supplements for primary and secondary prevention. Journal of American Medical Association, 2007(297), 842–857.

    Article  Google Scholar 

  16. Bjelakovic, G., et al. (2013). Antioxidant supplements to prevent mortality. Journal of American Medical Association, 310, 1178–1179.

    Article  CAS  Google Scholar 

  17. Group, A.-R. E. D. S. R. (2001). A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins c and e, beta carotene, and zinc for age-related macular degeneration and vision loss. Archives of Ophthalmology, 119(10), 1417–1436.

    Article  Google Scholar 

  18. The alpha-tocopherol, beta carotene cancer prevention study group. (1994). The effect of vitamin e and beta carotene on the incidence of lung cancer and other cancers in male smokers. New England Journal of Medicine, 330(15), 1029–1035.

    Article  Google Scholar 

  19. Omenn, G., et al. (1996). Risk factors for lung cancer and for intervention effects in CARET, the beta-carotene and retinol efficacy trial. Journal of the National Cancer Institute, 1996(88), 1550–1559.

    Article  Google Scholar 

  20. Snitz, B. E., et al. (2009). Ginkgo Biloba for preventing cognitive decline in older adults. Journal of the American Medical Association, 302, 2663.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  21. Grodstein, F., et al. (2013). Long-term multivitamin supplementation and cognitive function in men: A randomized trial. Annals of Internal Medicine, 159(12), 806–814.

    Article  PubMed Central  PubMed  Google Scholar 

  22. Hishikawa, N., et al. (2012). Effect of tumeric on Alzheimer’s disease with behavior and psychological symptoms of dementia. An International Quarterly Journal of Research in Ayurveda, 33(4), 499–504.

    Article  Google Scholar 

  23. Baker, W., et al. (2008). Effect of cinnamon on glucose control and lipid parameters. Diabetes Care, 3(1), 41–43.

    Article  Google Scholar 

  24. Hemila, H., et al. (2013). Vitamin C for preventing and treating the common cold. Cochrane Database of Systematic Review, 1, CD000253.

    Google Scholar 

  25. Barrett, B., et al. (2011). Placebo effects and the common cold: A randomized controlled trial. Annals of Family Medicine, 2011(9), 312–327.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Rifkin, E., Lazris, A. (2015). Vitamins and Supplements. In: Interpreting Health Benefits and Risks. Springer, Cham. https://doi.org/10.1007/978-3-319-11544-3_22

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-11544-3_22

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-11543-6

  • Online ISBN: 978-3-319-11544-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics